NEW YORK (GenomeWeb News) – Vermillion and Accelerate Diagnostics saw their share prices more than double during the first six months of 2013, pacing the GenomeWeb Daily News Index for the first half of the year.

Overall, the index was up nearly 17 percent from the end of 2012, beating the Dow Jones Industrial Average (+14 percent) and the Nasdaq Composite (+13 percent), but trailing the Nasdaq Biotech Index (+27 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.